JAMA Neurology · 2020 · 93 citations · 5 references
Life SciencesImmunologyNeurologyAutoimmunityClinical ImmunologyNeuroimmunologyAutoimmune DiseasesAutoimmune Neurological DisordersDemyelinating DiseasesDemyelinating DisordersLong-term Neurologic OutcomesMog Antibody DiseaseMog Antibody-associated DiseaseMyelin AntigensMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseMyelin-associated Glycoprotein
This cohort study reports outcomes of long-term follow-up in patients with myelin oligodendrocyte glycoprotein antibody–associated disorder.
5
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Juryńczyk, Silvia Messina, Mark Woodhall et al. · Brain · 2017 · 730 citations · Full text
Life Sciences, Immunology, Neurology +17
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults
Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart et al. · Neurology · 2018 · 532 citations
A. Sebastian López‐Chiriboga, Masoud Majed, James P. Fryer et al. · JAMA Neurology · 2018 · 407 citations · Full text
Life Sciences, Immunology, Neurology +17
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Yujuan Jiao, James P. Fryer, Vanda A. Lennon et al. · Neurology · 2013 · 239 citations · Full text
Life Sciences, Immunology, Neurology +12